论文信息 - Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi). - 字舞流文

Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi).

A. Allen | A. Grubstein | L. Roisman | N. Peled | T. Shochat | M. Ilouze | O. Rotem | E. Dudnik | A. Zer | A. Rozenblum | S. Geva | L. Fridel | Elias Bshara